Literature DB >> 14598127

Spongy matrix of hyaluronic acid and collagen as a cultured dermal substitute: evaluation in an animal test.

Kentaro Kubo1, Yoshimitsu Kuroyanagi.   

Abstract

The authors have developed a two-layered spongy matrix composed of hyaluronic acid (HA) and atelo-collagen (Col) as a cultured dermal substitute (CDS). This spongy matrix was applied to a full-thickness skin defect on the dorsum of Sprague-Dawley rats, and the wound conditions were observed over a period of 2 weeks. A piece of two-layered spongy matrix was applied to the wound, over which a commercially available polyurethane film dressing was applied. Both the macroscopic and the histological evaluations indicate that the two-layered spongy matrix is able to prepare a highly vascularized granulation tissue at an early stage. These findings suggest that this type of spongy matrix would be useful as a CDS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14598127     DOI: 10.1007/s100470300010

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  8 in total

1.  Comparative evaluation of re-epithelialization promoted by fresh or cryopreserved cultured dermal substitute.

Authors:  Naoto Yamada; Eiju Uchinuma; Yasuhiro Matsumoto; Yoshimitsu Kuroyanagi
Journal:  J Artif Organs       Date:  2008-12-17       Impact factor: 1.731

2.  A case of lower-extremity deep burn wounds with periosteal necrosis successfully treated by use of allogenic cultured dermal substitute.

Authors:  Naoki Ohara; Shoji Mihara; Hiroyuki Nihara; Narihiro Akimoto; Naoki Madokoro; Mikio Kawai; Hideki Noda; Michihiro Hide; Yasuhiro Matsumoto; Yoshimitsu Kuroyanagi
Journal:  J Artif Organs       Date:  2010-03-27       Impact factor: 1.731

3.  Skin substitutes based on allogenic fibroblasts or keratinocytes for chronic wounds not responding to conventional therapy: a retrospective observational study.

Authors:  Giorgio Pajardi; Vicenzo Rapisarda; Francesco Somalvico; Andrea Scotti; Giulia Lo Russo; Francesco Ciancio; Arturo Sgrò; Manuela Nebuloni; Raffaele Allevi; Maria L Torre; Emilio Trabucchi; Mario Marazzi
Journal:  Int Wound J       Date:  2014-02-12       Impact factor: 3.315

4.  Treatment of intractable skin ulcers caused by vascular insufficiency with allogeneic cultured dermal substitute: a report of eight cases.

Authors:  Tomonori Taniguchi; Yasuyuki Amoh; Kenichi Tanabe; Kensei Katsuoka; Yoshimitsu Kuroyanagi
Journal:  J Artif Organs       Date:  2011-08-23       Impact factor: 1.731

5.  Clinical trial of allogeneic cultured dermal substitutes for intractable skin ulcers.

Authors:  Naoto Yamada; Eiju Uchinuma; Yoshimitsu Kuroyanagi
Journal:  J Artif Organs       Date:  2011-12-03       Impact factor: 1.731

Review 6.  Epidermolysis Bullosa: A Review of the Tissue-Engineered Skin Substitutes Used to Treat Wounds.

Authors:  Alex du Rand; John M T Hunt; Vaughan Feisst; Hilary M Sheppard
Journal:  Mol Diagn Ther       Date:  2022-10-17       Impact factor: 4.476

7.  Standardization for mass production of allogeneic cultured dermal substitute by measuring the amount of VEGF, bFGF, HGF, TGF-beta, and IL-8.

Authors:  Akiko Hashimoto; Yoshimitsu Kuroyanagi
Journal:  J Artif Organs       Date:  2008-12-17       Impact factor: 1.731

Review 8.  A Concise Review on Tissue Engineered Artificial Skin Grafts for Chronic Wound Treatment: Can We Reconstruct Functional Skin Tissue In Vitro?

Authors:  Agata Przekora
Journal:  Cells       Date:  2020-07-06       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.